Benzo Lab

Mayo Clinic Arizona

Scottsdale · United States

NIH-funded
Rate this labNo reviews yet — be the first.

Research focus

NIH R01 · 2025

Pulmonary Rehabilitation for Rural Patients with COPD

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Globally, COPD prevalence is estimated to be 11.7%, and COPD is the fourth leading cause of death in the United States (US). The age-adjusted prevalence of COPD is double in rural (8.2%) compared to urban areas (4.7%). Rurality is associated with worse COPD outcomes, such as more severe dyspnea, poorer self-rated health, lower health-related quality of life (HRQL), and increased risk of acute exacerbations. Significant geographical barriers exist in treating and managing COPD in the United States. Less than 8% of rural patients have access to pulmonary rehabilitation, a critical treatment…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.

Reviews

← All labs at Mayo Clinic Arizona